Search

everythinglearnresearchcommunity

for

Search:↓

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Human hair follicles have a scent receptor that can influence hair growth.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Animals that change color with the seasons mainly do so in response to daylight changes, but climate change is causing camouflage problems that may require evolutionary changes.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

DHT may increase the risk of heart disease and death in elderly men.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

One minoxidil-sensitive potassium channel exists in human hair follicles.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

No treatment fully prevents hair loss from chemotherapy yet.

The document concludes that adult mammalian skin contains multiple stem cell populations with specific markers, important for understanding skin regeneration and related conditions.

Exosomes from dermal papilla cells can help grow hair and might treat hair loss.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.